BIO Earnings
Latest Revenue651.0M
Latest Net Income371.4M
| Period | EPS | Revenue | Net Income | Rev YoY | EPS YoY |
|---|
| Q2 2026 | $13.89 | 651.0M | 371.4M | -0.1% | +19.0% |
| Q1 2026 | -$19.55 | 592.1M | -527100000 | +1.1% | -953.7% |
| Q4 2025 | $26.70 | 693.2M | 720.0M | +3.9% | +204.4% |
| Q3 2025 | -$12.70 | 653.0M | -341900000 | +0.5% | -154.3% |
| Q2 2025 | $11.67 | 651.6M | 317.8M | +2.1% | +115.3% |
| Q1 2025 | $2.29 | 585.4M | 64.0M | -4.2% | -83.0% |
| Q4 2024 | -$25.57 | 667.5M | -715800000 | -2.0% | -310.5% |
| Q3 2024 | $23.37 | 649.7M | 653.2M | +2.8% | +540.3% |
| Q2 2024 | -$76.26 | 638.5M | -2165500000 | — | — |
| Q1 2024 | $13.46 | 610.8M | 383.9M | — | — |
| Q4 2023 | $12.15 | 681.1M | 349.7M | — | — |
| Q3 2023 | $3.65 | 632.1M | 106.3M | — | — |
Bio-Rad Laboratories, Inc.Class A (BIO) — Earnings